Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
pmid: | ||||
Bodin K et al. | Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4. | 2001 | J. Biol. Chem. | pmid:11514559 |
Bodin K et al. | Metabolism of 4 beta -hydroxycholesterol in humans. | 2002 | J. Biol. Chem. | pmid:12077124 |
Rontani JF and Aubert C | Electron ionization mass spectral fragmentation of cholestane-3beta,4alpha,5alpha-triol and cholestane-3beta,5alpha,6alpha/beta-triol bis- and tris-trimethylsilyl derivatives. | 2005 | Rapid Commun. Mass Spectrom. | pmid:15954177 |
Niemi M et al. | Effect of SLCO1B1 polymorphism on induction of CYP3A4 by rifampicin. | 2006 | Pharmacogenet. Genomics | pmid:16847425 |
Wide K et al. | Time course of the increase in 4beta-hydroxycholesterol concentration during carbamazepine treatment of paediatric patients with epilepsy. | 2008 | Br J Clin Pharmacol | pmid:18279471 |
Diczfalusy U et al. | 4Beta-hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians. | 2008 | Pharmacogenet. Genomics | pmid:18300941 |
Josephson F et al. | CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4beta-hydroxycholesterol levels. | 2008 | Eur. J. Clin. Pharmacol. | pmid:18458892 |
Kanebratt KP et al. | Cytochrome P450 induction by rifampicin in healthy subjects: determination using the Karolinska cocktail and the endogenous CYP3A4 marker 4beta-hydroxycholesterol. | 2008 | Clin. Pharmacol. Ther. | pmid:18650803 |
Honda A et al. | Highly sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI-MS/MS. | 2009 | J. Lipid Res. | pmid:18815436 |